By Sheeba M. | May 30, 2026
Canopy Growth Q4 Earnings Signal Recovery Path in Canadian Market
Canopy Growth (CGC on TSX, CGBF on US OTC) reported Q4 fiscal 2024 results this week, and the numbers tell a story of disciplined restructuring paying dividends. Revenue came in at CAD $109M, with EBITDA turning positive for the first time in three quarters. The shift isn’t flashy—but it matters.
The Canadian cannabis market remains structurally challenged by illicit competition and retail fragmentation, but Canopy’s strategic refocus on higher-margin products and premium segment positioning is working. Management trimmed SG&A spending by 18% year-over-year while maintaining production capacity, a textbook operational playbook for a mature cannabis producer finding its footing in a commoditized landscape.
What investors should watch: management’s full-year 2025 guidance will be the tell. If Canopy commits to EBITDA-positive operations—not just one-quarter blips—the stock could attract institutional capital that’s been sitting on sidelines since the 2021 peak crash. The insider consensus among cannabis finance analysts is that CGC has finally bottomed structurally, pending continued execution.
Internationally, Canopy’s Australia and UK operations continue expanding, offering long-term optionality that domestic Canada revenue can’t provide. This is a company in transition from hype to fundamentals.
Track the Major Players
Monitor these related tickers on the Weedstock Real-Time Tracker:
- CGC (Canopy Growth) — TSX large-cap benchmark
- CGBF (Canopy Growth US OTC) — US trading access
- TLRY (Tilray Brands) — peer comparison
- CURLF (Curaleaf) — MSO alternative
Sources
- Canopy Growth Investor Relations — Official quarterly filings and guidance
- Reuters CGC.TO — Market data and news
Track cannabis stocks with the Weedstock Real-Time Tracker